Clinical data indicate that the severity of the symptoms found in AATD patients is highly variable and neither AAT serum levels nor phenotype are sufficient to identify which patients develop severe COPD [37]. Here, SERPINA1 is linked to alpha 1-antitrypsin deficiency.